Cargando…

Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer

Degree of expression of programmed death-ligand 1 (PD-L1) is related with Immune check point inhibitors (ICIs) response but it needs sufficient tumor tissue. There is unmet need for easily accessible and prognostic peripheral blood (PB) biomarkers. We investigated the application of serum peripheral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ye Jin, Park, Young Sik, Lee, Hyun Woo, Park, Tae Yoen, Lee, Jung Kyu, Heo, Eun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755768/ https://www.ncbi.nlm.nih.gov/pubmed/35022510 http://dx.doi.org/10.1038/s41598-021-04630-9

Ejemplares similares

Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
por: Obirikorang, Christian, et al.
Publicado: (2012)

Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer
por: Heo, Jaesung, et al.
Publicado: (2016)

Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer
por: Heo, Jaesung, et al.
Publicado: (2016)

Utility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in Kenya
por: Githinji, Nyawira, et al.
Publicado: (2011)

Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma
por: Lee, Ji Won, et al.
Publicado: (2022)

Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor–Associated Myocarditis
por: Drobni, Zsofia D., et al.
Publicado: (2020)

Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia
por: Wondimeneh, Yitayih, et al.
Publicado: (2012)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Decrease of peripheral blood lymphocyte count predicts response to neoadjuvant chemotherapy in breast cancer patients
por: Lee, Ok Hee, et al.
Publicado: (2020)

Correction: Total Lymphocyte Count as surrogate marker for CD4 Cell Count in HIV-Infected Individuals in Gondar University Hospital, Northwest Ethiopia
por: Wondimeneh, Yitayih, et al.
Publicado: (2013)

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors
por: Young, Richard Benjamin, et al.
Publicado: (2022)

Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India
por: Srirangaraj, S., et al.
Publicado: (2012)

Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
por: Galland, Loïck, et al.
Publicado: (2021)

Comparison of Surrogate Markers as Measures of Uncomplicated Insulin Resistance in Korean Adults
por: Kim, Tae Jong, et al.
Publicado: (2016)

Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients
por: Kim, Sung-Tae, et al.
Publicado: (2011)

Peripheral Blood Stem Cell Harvest HPC Count Is an Effective Surrogate Marker for CD34+ Cell Count in Allogeneic Stem Cell Transplant Setting
por: Jamal, Aisha, et al.
Publicado: (2020)

Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
por: So, Wei Zheng, et al.
Publicado: (2022)

The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase‐positive non‐small cell lung cancer
por: Heo, Ja Yoon, et al.
Publicado: (2019)

Longitudinal decrease in platelet counts as a surrogate marker of liver fibrosis
por: Gotlieb, Neta, et al.
Publicado: (2020)

Different treatment response to systemic corticosteroids according to white blood cell counts in severe COVID-19 patients
por: Choi, Kwang Yong, et al.
Publicado: (2022)

C-Type Natriuretic Peptide as a Surrogate Marker in Variant Angina Pectoris
por: Lee, Dong-Hyeon, et al.
Publicado: (2013)

The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia
por: Lee, Hyun Woo, et al.
Publicado: (2021)

A cleavage-based surrogate reporter for the evaluation of CRISPR–Cas9 cleavage efficiency
por: Jung, Soo Bin, et al.
Publicado: (2021)

Value of the use of absolute lymphocyte as surrogate for CD4 count in resource poor situations
por: Adegbamigbe, Oluwafemi Johanson, et al.
Publicado: (2014)

hIL‐7‐hyFc, A Long‐Acting IL‐7, Increased Absolute Lymphocyte Count in Healthy Subjects
por: Lee, Sang Won, et al.
Publicado: (2020)

Body Mass Index, Haemoglobin, and Total Lymphocyte Count as a Surrogate for CD4 Count in Resource Limited Settings
por: Kwantwi, Louis Boafo, et al.
Publicado: (2017)

Relationship between Peripheral Leukocyte Count and the Severity of Stable Angina Determined by Coronary Angiography
por: Park, Seung Ha, et al.
Publicado: (2004)

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
por: Kang, Tae Heung, et al.
Publicado: (2020)

Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 Cell Count in the Management of HIV-Infected Patients in Resource-Limited Settings: A Study from China
por: Chen, Jieqing, et al.
Publicado: (2013)

Tumor-infiltrating lymphocyte enrichment predicted by CT radiomics analysis is associated with clinical outcomes of non-small cell lung cancer patients receiving immune checkpoint inhibitors
por: Park, Changhee, et al.
Publicado: (2023)

Prognostic Significance of Absolute Lymphocyte Count/Absolute Monocyte Count Ratio at Diagnosis in Patients with Multiple Myeloma
por: Shin, Su-Jin, et al.
Publicado: (2013)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Reference ranges for induced sputum eosinophil counts in Korean adult population
por: Kim, Mi-Yeong, et al.
Publicado: (2014)

Prognostic Significance of Initial Absolute Lymphocyte Count in Adjuvant Radiotherapy for Pancreatic Adenocarcinoma
por: Heo, Jaesung, et al.
Publicado: (2022)

CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study
por: Calvet, Joan, et al.
Publicado: (2020)

Associations between absolute neutrophil count and lymphocyte-predominant breast cancer
por: Yoon, Chang Ik, et al.
Publicado: (2019)

Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer
por: Park, Se Jun, et al.
Publicado: (2021)

Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance
por: Oh, Seung Yeop, et al.
Publicado: (2018)

Utility of total lymphocyte count as a surrogate for absolute CD4 count in the adult Indian HIV population: A prospective study
por: Karanth, Suman S., et al.
Publicado: (2014)

Peripheral Blood Lymphocyte Subsets Predict the Efficacy of Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
por: Miao, Kang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bneq1kqih08gde9d6i5qdigr0g